Fig. 1From: Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trialPatient enrollment: Flow chart of the Phosfood II dietary intervention60 patients were randomized and allocated to the FO (n = 31) or MPL (n = 29) group. After six weeks of dietary intervention, 18 FO patients and 15 MPL patients could be analyzed (n = 33). FO = fishoil, MPL = marine phospholipidsBack to article page